Morton Grove Pharmaceuticals is recalling approximately 127,392 bottles of Hydroxyzine Hydrochloride Oral Solution, USP (Syrup), 10 mg/5 mL, a prescription medication used to treat anxiety and itching. This recall was initiated because the product failed quality tests for impurities and degradation, specifically showing out-of-specification levels for an unknown substance and 4-chlorobenzophenone. These impurities mean the medication may not meet safety and quality standards over time. Consumers should contact their healthcare provider or pharmacist to discuss alternatives and instructions for returning the product.
The presence of unknown impurities and 4-chlorobenzophenone indicates that the chemical stability of the medication has been compromised, which could potentially lead to reduced effectiveness or unintended side effects.
Contact healthcare provider or pharmacist and return product.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.